Exact Mass: 520.2703846

A taxane diterpenoid that is taxusin in which the hydrogen at the 7beta position is replaced by a hydroxy group.

Dolichol diphosphate

alpha-(3-methylbut-2-en-1-yl)-omega-(4-{[hydroxy(phosphonooxy)phosphoryl]oxy}-2-methylbutyl)poly[(2E)-2-methylbut-2-ene-1,4-diyl]

C25H46O7P2 (520.2718626)

Withaperuvin D

7-[1-(4,5-dimethyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)-1-hydroxyethyl]-4,7,16,17-tetrahydroxy-8,12-dimethyl-18-oxapentacyclo[13.2.1.0³,¹¹.0⁴,⁸.0¹²,¹⁷]octadecan-13-one

Withaperuvin D is found in fruits. Withaperuvin D is a constituent of leaves of Physalis peruviana (Cape gooseberry) Constituent of leaves of Physalis peruviana (Cape gooseberry). Withaperuvin D is found in fruits.

rac-4-Hydroxy-4-O-(beta-D-glucuronide)-all-trans-retinyl acetate

(2R,3S,4R,5R,6R)-6-{[(1R)-3-[(1E,3E,5E,7E)-9-(acetyloxy)-3,7-dimethylnona-1,3,5,7-tetraen-1-yl]-2,4,4-trimethylcyclohex-2-en-1-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

This compound belongs to the family of Diterpene Glycosides. These are diterpenes in which an isoprene unit is glycosylated.

Nastorazepide

Calcium bis((R)-(-)-3-(3-(5-cyclohexyl-1-(3,3-dimethyl-2-oxo-butyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo(b)(1,4)diazepin-3-yl)ureido)benzoate)

A diterpenoid of the clerodane group isolated from the leaves and flowers of Casearia nigrescens. It exhibits cytotoxicity against A2780 human ovarian cancer cell line.

Renillin C

(+)-2-Deacetyl-5-decinnamoyltaxinine J

neocynapanogenin C 3-O-beta-D-oleandroside|paniculatumoside B

methyl-ent-7alpha-acetoxy-1alpha-(2-methyl-2,3-epoxybutyryloxy)-9alpha,15alpha-dihydroxykaur-16-en-19-oate|methyl-ent-7alpha-acetoxy-1alpha-<2-methyl-2,3-epoxybutyryloxy>-9alpha,15alpha-dihydroxykaur-16-en-19-oate

methyl-ent-7alpha-acetoxy-1alpha-(2-methyl-2,3-epoxybutyryloxy)-9alpha,15alpha-dihydroxykaur-16-en-19-oate|methyl-ent-7alpha-acetoxy-1alpha-<2-methyl-2,3-epoxybutyryloxy>-9alpha,15alpha-dihydroxykaur-16-en-19-oate

14-Hydroxy-3beta-(O3-methyl-beta-D-fucopyranosyloxy)-14beta-pregn-5-en-11,15,20-trion|14-hydroxy-3beta-(O3-methyl-beta-D-fucopyranosyloxy)-14beta-pregn-5-ene-11,15,20-trione

22-dehydro-12-hydroxy-29-nor-cyasterone

Glaucogenin C mono-D-thevetoside

5alpha,9alpha,10beta,13alpha-tetraacetoxy-11(15->1)abeotaxa-4(20),11-dien-15-ol|5alpha,9alpha,10beta,13alpha-tetraacetoxy-15-hydroxy-11(15->1)-abeo-taxa-4(20),11-diene|5??,9??,10??,13??-Tetraacetoxy-15-hydroxy-11(15鈥樏傗垎1)-abeo-taxa-4(20),11-diene

5alpha,9alpha,10beta,13alpha-tetraacetoxy-11(15->1)abeotaxa-4(20),11-dien-15-ol|5alpha,9alpha,10beta,13alpha-tetraacetoxy-15-hydroxy-11(15->1)-abeo-taxa-4(20),11-diene|5??,9??,10??,13??-Tetraacetoxy-15-hydroxy-11(15鈥樏傗垎1)-abeo-taxa-4(20),11-diene

C28H40O9_1(2H)-Naphthalenone, 2,7-bis(acetyloxy)-4-[(3E)-2,5-bis(acetyloxy)-3-methyl-3-penten-1-yl]octahydro-4a,8,8-trimethyl-3-methylene

NCGC00380512-01_C28H40O9_1(2H)-Naphthalenone, 2,7-bis(acetyloxy)-4-[(3E)-2,5-bis(acetyloxy)-3-methyl-3-penten-1-yl]octahydro-4a,8,8-trimethyl-3-methylene-

C28H38F6O2 (520.2775839999999)

stanozolol-3-OH-O-glucuronide

C27H40N2O8 (520.278452)

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]-3-phenylpropanoic acid

C23H36N8O6 (520.2757676)

Thr-Lys-Ala-Val-Cys

C21H40N6O7S (520.267905)

26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D2 / 26,26,26,27,27,27-hexafluoro-25-hydroxyergocalciferol

Withaperuvin D

7-[1-(4,5-dimethyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)-1-hydroxyethyl]-4,7,16,17-tetrahydroxy-8,12-dimethyl-18-oxapentacyclo[13.2.1.0^{3,11}.0^{4,8}.0^{12,17}]octadecan-13-one

PCTR2

16R-(S-cysteinylglycinyl)-17S-hydroxy-4Z,7Z,10Z,12E,14E,19Z-docosahexaenoic acid

MCTR2

13R-(S-cysteinylglycinyl)-14S-hydroxy-4Z,7Z,9E,11E,16Z,19Z-docosahexaenoic acid

OOB-PA

1-(9Z-octadecenoyl)-2-(4-oxobutryl)-sn-glycero-3-phosphate

C25H45O9P (520.2801049999999)

Withaperuvin

17S,20S,22R-4beta,5beta,6alpha,14alpha,17beta,20alpha-hexahydroxy-1-oxo-ergosta-2,24-dienolide

C28H38F6O2 (520.2775839999999)

26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D2

(5E,7E,22E)-(3S)-26,26,26,27,27,27-hexafluoro-9,10-seco-5,7,10(19),22-ergostatetraene-3,25-diol

26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D2

(5Z,7E,22E)-(3S)-26,26,26,27,27,27-hexafluoro-9,10-seco-5,7,10(19),22-ergostatetraene-3,25-diol

C28H38O2F6 (520.2775839999999)

Gallopamil hydrochloride

C28H41ClN2O5 (520.2703846)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

methoxy-(-)-verapamil hydrochloride

C28H41ClN2O5 (520.2703846)

Silicic acid, ethyl ester

C34H36N2O3 (520.2725786)

Nastorazepide

Nastorazepide (Z-360) is a selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity. Target：CCK-2 in vitro: Z-360 binds to the gastrin/CCK-2 receptor, thereby preventing receptor activation by gastrin, a peptide hormone frequently associated with the proliferation of gastrointestinal and pancreatic tumor cells. Check for active clinical trials or closed clinical trials using this agent. in vivo: Z-360 is a novel orally active CCK-2/gastrin receptor antagonist, significantly inhibits the growth of subcutaneous xenografts of human pancreatic tumor cells in mice, and that Z-360 combined with gemcitabine prolonged survival in a pancreatic carcinoma orthotopic xenograft mice.

(4Z,7Z,9E,11E,13R,14S,16Z,19Z)-13-[(2R)-2-amino-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-14-hydroxydocosa-4,7,9,11,16,19-hexaenoic acid

Phe-Gln-Ala-Arg

C23H36N8O6 (520.2757676)

Nastorazepide

Calcium bis((R)-(-)-3-(3-(5-cyclohexyl-1-(3,3-dimethyl-2-oxo-butyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo(b)(1,4)diazepin-3-yl)ureido)benzoate)

7beta-Hydroxytaxa-4(20),11-diene-5alpha,9alpha,10beta,13alpha-tetrayl tetraacetate

5-(2-amino-1-hydroxyethyl)-2-[[(2R,3R,4S,5R,6R)-5-carbamoyloxy-3-(3,6-diaminohexanoylamino)-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-4,5-dihydro-1H-imidazole-4-carboxylic acid

C19H36N8O9 (520.2605126)

Ajubractin B

A docosanoid that is (14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid in which a cysteinylglycinyl group is attached at position 13R via a sulfide linkage.

16(S)-glycinylcystein-S-yl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid

(1s,2r,5r,10r,11r,14r,16s,17r,20s,21s,22r)-11,16,21-trihydroxy-8-isopropyl-14-methoxy-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricosa-8,12-dien-17-yl acetate

14beta-hydroxytaxusin

14β-hydroxytaxusin

(6r)-6-[(1s)-1-[(1s,3ar,3br,5s,5as,6s,9ar,9bs,11as)-1,3a,5,5a,6-pentahydroxy-9a,11a-dimethyl-9-oxo-2h,3h,3bh,4h,5h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3,4-dimethyl-5,6-dihydropyran-2-one

8-[(3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1(21),10-dien-14-one

1-acetyl-7-[(3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-1-hydroxy-9a,11a-dimethyl-2h,3ah,3bh,4h,6h,7h,8h,9h,9bh,11h-cyclopenta[a]phenanthrene-3,10-dione

(1s,2s,4s,5r,8r,9s,10r,13r,15r)-2-(acetyloxy)-10,15-dihydroxy-5-(methoxycarbonyl)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-8-yl (2s,3r)-2,3-dimethyloxirane-2-carboxylate

(1s,2s,4s,5r,8r,9s,10r,13r,15r)-2-(acetyloxy)-10,15-dihydroxy-5-(methoxycarbonyl)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-8-yl (2s,3r)-2,3-dimethyloxirane-2-carboxylate

2-amino-1-{10-benzyl-8,11-dihydroxy-16-methoxy-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,15(19),16-hexaen-6-yl}-3-methylpentan-1-one

2-amino-1-[(13e)-10-benzyl-8,11-dihydroxy-16-methoxy-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,15(19),16-hexaen-6-yl]-3-methylpentan-1-one

(1e,4s,5r,8s,13r,16r,19r,21r,22r)-21-hydroxy-8-{[(2r,4r,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1,10-dien-14-one

(1e,4s,5r,8s,13r,16r,19r,21r,22r)-21-hydroxy-8-{[(2r,4r,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1,10-dien-14-one

(1s,3r,5s,8r,9r,10r,13r,14r)-9,10,13-tris(acetyloxy)-14-hydroxy-8,12,15,15-tetramethyl-4-methylidenetricyclo[9.3.1.0³,⁸]pentadec-11-en-5-yl acetate

(1r,2s,4r,6s,8r,9r,10s,11r,13s,15r)-2,6,8-tris(acetyloxy)-11-hydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate

(2e,9z,13e)-15-(acetyloxy)-2-[2-(acetyloxy)ethylidene]-10-[(acetyloxy)methyl]-14-methyl-6-methylidene-5-oxopentadeca-9,13-dien-1-yl acetate

(4s,5r,8s,13r,16s,19r,22s)-8-{[(2r,3r,4s,5r,6r)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1(21),10-dien-14-one

(4s,5r,8s,13r,16s,19r,22s)-8-{[(2r,3r,4s,5r,6r)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1(21),10-dien-14-one

(1s,2r,3r,4r,7s,8z,12s,13s,14s)-2,14-bis(acetyloxy)-3-hydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,16-dien-12-yl butanoate

(2r)-2-[(1r)-3-methoxy-3-oxo-1-{[(1s,2r,7s,10r,11s,14r,15r,16r,19s)-10,14,16-trimethyl-17,20,21-trioxahexacyclo[14.4.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,¹⁹]henicos-4-en-7-yl]oxy}propoxy]propanoic acid

(2r)-2-[(1r)-3-methoxy-3-oxo-1-{[(1s,2r,7s,10r,11s,14r,15r,16r,19s)-10,14,16-trimethyl-17,20,21-trioxahexacyclo[14.4.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,¹⁹]henicos-4-en-7-yl]oxy}propoxy]propanoic acid

(1s,2s,3'r,4s,4'r,6s,7s,8r,9r,10s,13s,14r,17s,18s,19r,21r)-7,8,17,18-tetrahydroxy-3',4',8,10,14-pentamethyl-5,20-dioxaspiro[hexacyclo[11.9.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹.0¹⁹,²¹]docosane-6,2'-oxolane]-5',15-dione

(1s,2s,3'r,4s,4'r,6s,7s,8r,9r,10s,13s,14r,17s,18s,19r,21r)-7,8,17,18-tetrahydroxy-3',4',8,10,14-pentamethyl-5,20-dioxaspiro[hexacyclo[11.9.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹.0¹⁹,²¹]docosane-6,2'-oxolane]-5',15-dione

2-(methylamino)-3-phenyl-1-[8,11,16-trihydroxy-10-(sec-butyl)-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,15(19),16-hexaen-6-yl]propan-1-one

(4s,5r,7r,8r,13r,16s,19r,22r)-7-hydroxy-8-{[(2s,4r,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1(21),10-dien-14-one

(4s,5r,7r,8r,13r,16s,19r,22r)-7-hydroxy-8-{[(2s,4r,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1(21),10-dien-14-one

(4s,5r,8s,13s,16s,19r,22r)-8-{[(2r,3r,4s,5r,6r)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1(21),10-dien-14-one

(4s,5r,8s,13s,16s,19r,22r)-8-{[(2r,3r,4s,5r,6r)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1(21),10-dien-14-one

[(1r,2s,5s,6r,9r,13r,14r,16r)-2,6-bis(acetyloxy)-5-[(acetyloxy)methyl]-5,9-dimethyl-15-oxapentacyclo[11.3.1.0¹,¹⁰.0⁴,⁹.0¹⁴,¹⁶]heptadecan-14-yl]methyl acetate

9,12-bis(acetyloxy)-3,14-dihydroxy-7,11,15,15,16,16-hexamethyl-10-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-1,7-dien-6-yl acetate